STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
251
13F, latest reported quarter
What the filings say about DOX
Insiders, 180 days
-$29.0K net sold
1 seller · 0% of sales under a 10b5-1 plan
Congress, 1 year
0 bought · 1 sold
Latest: sale, 2025-11-12
Planned sales (Form 144), 90 days
$1.9M
1 notice
Amdocs insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, AMDOCS LTD insiders sold a net $29.0K of stock across 1 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Foreign private issuer: most of its insiders are exempt from SEC Form 4, but some still file it; those filings are listed below, and the record may be incomplete.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 29.9% of the 1,550 shares held after it.
No other insider sold within 30 days.
251 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: See Remarks Smith Matthew E. sold about $29.0K of DOX on May 29, 2026, the largest insider sale at the company on our record; 251 funds added in the latest 13F quarter.
1 transaction on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
DOX planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Tamar Rappaport Dagim
Filed 2026-08-06
$1.9M
Rapaport-Dagim Tamar
Filed 2026-07-28
$678.6K
Rapaport-Dagim Tamar
Filed 2026-07-23
$5.5M
Sheffer Yhoshua
Filed 2026-06-23
$5.2M
DOX mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Monarch Dividend Plus Index ETF
$2.0M position · as of 2026-05-31
3.4%
Saratoga Technology & Communication Portfolio
$1.1M position · as of 2026-05-31
2.6%
PIN OAK EQUITY FUND
$3.7M position · as of 2026-07-31
2.5%
Classic Value Fund
$10.6M position · as of 2026-07-31
1.9%
DEAN EQUITY INCOME FUND
$1.4M position · as of 2026-06-30
1.9%
Saturna Core Fund
$780.8K position · as of 2026-05-31
1.8%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $29.0K sold by insiders over 180 days, 251 funds added last quarter, $1.9M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$5.0B
four quarters, 2023-10-01 to 2024-09-30
Revenue, TTM DOX
FY Sep 2024
$5.0B
FY Sep 2023
$4.9B
FY Sep 2022
$4.6B
FY Sep 2021
$4.3B
FY Sep 2020
$4.2B
Sep 2024
$1.3B
Jun 2024
$1.3B
Mar 2024
$1.2B
Dec 2023
$1.2B
Sep 2023
$1.2B
Jun 2023
$1.2B
Mar 2023
$1.2B
Dec 2022
$1.2B
At each fiscal year end
Single quarter
Net margin, TTM
+9.9%
net income over revenue, 2023-10-01 to 2024-09-30
Net margin, TTM DOX
FY Sep 2024
+9.9%
FY Sep 2023
+11.1%
FY Sep 2022
+12.0%
FY Sep 2021
+16.1%
FY Sep 2020
+11.9%
Sep 2024
+6.8%
Jun 2024
+11.2%
Mar 2024
+9.5%
Dec 2023
+11.9%
Sep 2023
+8.2%
Jun 2023
+12.9%
Mar 2023
+12.2%
Dec 2022
+10.9%
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
fewer than four consecutive quarters of operating cash flow
Free cash flow, TTM DOX
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
n/a
FY Sep 2021
n/a
FY Sep 2020
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Single quarter
Debt to equity
0.19x
long-term 2024-09-30 plus current 2021-09-30 (36 months older than the period end); equity 2024-09-30
Debt to equity DOX
FY Sep 2024
0.19x
FY Sep 2023
0.18x
FY Sep 2022
0.18x
FY Sep 2021
0.18x
FY Sep 2020
0.21x
Sep 2024
0.19x
Jun 2024
0.18x
Mar 2024
0.18x
Dec 2023
0.18x
Sep 2023
0.18x
Jun 2023
0.18x
Mar 2023
0.18x
Dec 2022
0.18x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
needs four quarters of operating cash flow
Cash flow to debt DOX
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
n/a
FY Sep 2021
n/a
FY Sep 2020
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+14.1%
TTM net income over average of 2023-09-30 and 2024-09-30
Return on equity DOX
FY Sep 2024
+14.1%
FY Sep 2023
+15.4%
FY Sep 2022
+15.5%
FY Sep 2021
+19.1%
FY Sep 2020
+14.0%
Sep 2024
+14.1%
Jun 2024
+14.5%
Mar 2024
+15.0%
Dec 2023
+15.9%
Sep 2023
+15.4%
Jun 2023
+16.0%
Mar 2023
+15.1%
Dec 2022
+15.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+7.7%
TTM net income over average of 2023-09-30 and 2024-09-30
Return on assets DOX
FY Sep 2024
+7.7%
FY Sep 2023
+8.4%
FY Sep 2022
+8.5%
FY Sep 2021
+10.7%
FY Sep 2020
+8.6%
Sep 2024
+7.7%
Jun 2024
+7.9%
Mar 2024
+8.2%
Dec 2023
+8.7%
Sep 2023
+8.4%
Jun 2023
+8.8%
Mar 2023
+8.3%
Dec 2022
+8.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on invested capital DOX
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
n/a
FY Sep 2021
n/a
FY Sep 2020
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+12.6%
operating income (EBIT proxy) over average of 2023-09-30 and 2024-09-30 minus current liabilities
Return on capital employed DOX
FY Sep 2024
+12.6%
FY Sep 2023
+12.8%
FY Sep 2022
+12.9%
FY Sep 2021
+11.6%
FY Sep 2020
+12.9%
Sep 2024
+12.6%
Jun 2024
+12.8%
Mar 2024
+13.0%
Dec 2023
+13.5%
Sep 2023
+12.8%
Jun 2023
+13.3%
Mar 2023
+13.0%
Dec 2022
+12.7%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
14.78x
close 2026-10-26 over four quarters of diluted EPS, 2023-10-01 to 2024-09-30
P/E, trailing DOX
FY Sep 2024
20.63x
FY Sep 2023
18.86x
FY Sep 2022
17.89x
FY Sep 2021
14.28x
FY Sep 2020
15.52x
Sep 2024
20.63x
Jun 2024
18.18x
Mar 2024
20.31x
Dec 2023
18.82x
Sep 2023
18.86x
Jun 2023
21.17x
Mar 2023
21.87x
Dec 2022
20.47x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$7.4B
market value at close 2026-10-26 on 2024-09-30 shares, plus long-term 2024-09-30 plus current 2021-09-30 (36 months older than the period end), minus cash 2024-09-30
Enterprise value DOX
FY Sep 2024
$10.2B
FY Sep 2023
$10.0B
FY Sep 2022
$9.7B
FY Sep 2021
$9.4B
FY Sep 2020
$7.3B
Sep 2024
$10.2B
Jun 2024
$9.4B
Mar 2024
$10.7B
Dec 2023
$10.4B
Sep 2023
$10.0B
Jun 2023
$12.0B
Mar 2023
$11.7B
Dec 2022
$11.1B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
fewer than four consecutive quarters of operating cash flow
FCF yield DOX
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
n/a
FY Sep 2021
n/a
FY Sep 2020
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
Dec 2022
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -5%, PEG needs growth
PEG, trailing DOX
FY Sep 2024
n/a
FY Sep 2023
20.93x
FY Sep 2022
n/a
FY Sep 2021
0.33x
FY Sep 2020
2.45x
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
14.86x
Dec 2023
3.63x
Sep 2023
20.93x
Jun 2023
2.98x
Mar 2023
n/a
Dec 2022
2.39x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
DOX ranks highest on profitability (75th percentile) and financial health (48th), and lowest on risk and compliance (30th), among Software & IT peers.
Profitability
75
Inputs
Return on equity+14.1% · 70 pct, sector of 286
Return on assets+7.7% · 76 pct, sector of 381
Return on invested capitaltax provision or pre-tax income not filed for the four quarters
Return on capital employed+12.6% · 78 pct, sector of 294
Financial health
48
Inputs
Debt to equity0.19x · 48 pct, sector of 288
Cash flow to debtneeds four quarters of operating cash flow
Growth
31
Inputs
Revenue growth, YoY+2.4% · 35 pct, sector of 480
Backlog growth, YoY-6.0% · 27 pct, sector of 182
Insider conviction
38
Inputs
Net Form 4 buying (codes P and S), 180d-$29K · 77 pct, sector of 285
Insider buyers, 180d0 · 0 pct, sector of 290
Institutional and government
46
Inputs
Funds adding, latest quarter251 · 81 pct, sector of 415
Congress net buyers, 365d-1 · 11 pct, sector of 72
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
30
Inputs
Short interest, % of float+8.9% · 30 pct, sector of 530
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
DOX filings, in plain words
Are Amdocs insiders buying or selling DOX?
In the 180 days to 2026-10-28, Amdocs insiders were net sellers, a net $29.0K across purchases and sales reported on Form 4, by 1 seller.
Have members of Congress traded DOX?
Yes. In the year to 2026-10-28, 0 House members disclosed buying DOX and 1 House member disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2025-11-12.
Are there planned insider sales of DOX?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $1.9M of stock; the latest, by Tamar Rappaport Dagim, was filed 2026-08-06.
Read the full summary
In the 180 days to 2026-10-28, Amdocs insiders were net sellers of DOX, a net $29.0K across purchases and sales reported on Form 4 by 1 seller. In the year to 2026-10-28, 0 members of Congress disclosed buying DOX and 1 member disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2025-11-12. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $1.9M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.